Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Y4RS
|
|||
Former ID |
DNC001891
|
|||
Drug Name |
ISIS 4719
|
|||
Drug Type |
Antisense drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Company |
Isis Pharmaceuticals
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | E-selectin messenger RNA (SELE mRNA) | Target Info | . | [1] |
KEGG Pathway | Cell adhesion molecules (CAMs) | |||
TNF signaling pathway | ||||
African trypanosomiasis | ||||
Malaria | ||||
NetPath Pathway | IL5 Signaling Pathway | |||
IL4 Signaling Pathway | ||||
TNFalpha Signaling Pathway | ||||
ID Signaling Pathway | ||||
Pathway Interaction Database | Thromboxane A2 receptor signaling | |||
Glucocorticoid receptor regulatory network | ||||
ATF-2 transcription factor network | ||||
Reactome | Cell surface interactions at the vascular wall | |||
WikiPathways | Human Complement System | |||
TNF alpha Signaling Pathway | ||||
Cell surface interactions at the vascular wall |
References | Top | |||
---|---|---|---|---|
REF 1 | US patent application no. 5,843,738, Oligonucleotide modulation of cell adhesion. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.